Pennon Fundamental Analysis: PNN Revenue, Margins, Debt and Valuation

Pennon Group asked its shareholders for money again on 7 October 2026, and the terms tell you how urgent the ask was. The company announced a fully underwritten rights issue of £550m — 220,257,997 new shares on a seven-for-15 basis at 250p — a 44.7% discount to the 452p close of 6 October and a 35.5% discount to the theoretical ex-rights price of 387.73p. Alongside it, the dividend was rebased: the payout for FY2026/27 is now expected at about £125m, against £138m for FY2025/26, which the company describes as an underlying per-share reduction of roughly 30% to about 18p.

For anyone running a Pennon fundamental analysis, that is the whole question in one paragraph. The money is going into a real regulated asset: AMP8 capital investment now stands at about £3.6bn, roughly £1bn above the plan built on Ofwat's Final Determination, and Pennon expects regulatory capital value growth of more than 40% across the period against the 34% originally guided. Regulated asset growth of that order is the most reliable earnings engine a water utility has. The counterweight is that this is the second equity call in 20 months, after a £490m rights issue at 264p in January 2025 that was presented as funding the period, and it arrives against net debt of £4,508.9m. What the numbers support is a bigger, better-capitalised asset base; what would have to go right is the operational delivery that two successive raises have now been asked to pay for.

What actually happened

The issue is fully underwritten by Barclays and Morgan Stanley and raises roughly £530m net of expenses. At 220,257,997 new shares against the 471,983,593 ordinary shares in issue at 31 March 2026, the new stock represents about 31.8% of the enlarged capital — so a holder who does not take up rights and does not sell them is diluted by up to that much.

Pennon is targeting gearing of no more than 65% of RCV for its regulated water businesses throughout AMP8, inside a long-term policy range of 55% to 65%. About £170m of the additional investment is expected to be recovered through Ofwat's 2027 and 2028 cost change processes, subject to approval — which is to say that part of the extra spend depends on the regulator agreeing to it later.

The second half of the announcement is an operational reset from new chief executive Keith Haslett, organised around five pillars: people and culture, operational excellence, asset management and reliability, environmental performance, and customer transformation. Steps already taken include a new Chief Asset Officer and Chief People Officer, centralised asset management and the insourcing of leakage technicians. Haslett's framing was that the review identified areas where the group needed to improve operational performance and the management and maintenance of its assets. A proposed disposal of Pennon Power sits alongside it, with about £25m of proceeds earmarked for behind-the-meter projects.

Shares fell heavily on 7 October. The size of the fall is reported inconsistently across sources — figures between roughly 16% and 24% appear in different accounts, taken at different points in a volatile session — so no single closing figure is reliable enough to publish here. What is consistent is the characterisation: Reuters described a 15-year low and Bloomberg a two-decade low. Jefferies had flagged the risk of exactly this combination, an equity raise plus a dividend cut, ahead of the announcement.

Why the market reacted the way it did

A deeply discounted rights issue is not, by itself, a verdict on a business. The theoretical ex-rights price already accounts for the cash coming in, so the mechanical effect of a 44.7% discount is arithmetic rather than judgement. The repricing went beyond that arithmetic, and the reason is credibility rather than capital.

Pennon told the market in early 2025 that £490m funded its AMP8 programme. Twenty months later it needs £550m more, the programme has grown by about £1bn, and the dividend — the single reason a large share of the register owns a water utility at all — has been cut by around 30% per share on an underlying basis. Each of those three facts is defensible on its own. Together they reset the market's estimate of how much more capital this balance sheet might need, and of how much of the extra spend is value-creating RCV growth versus the cost of fixing operational performance that should not have needed fixing.

The dividend mechanics are worth untangling, because two per-share numbers are in circulation and they measure different things. Pennon paid 29.29p for FY2025/26, itself down from 31.57p after the January 2025 issue enlarged the share count. Spreading the new £125m guidance across an enlarged capital of roughly 692m shares gives about 18p. The gap between 29.29p and 18p is wider than 30% on simple arithmetic; the company's roughly 30% figure is the underlying reduction after adjusting for the bonus element embedded in a discounted rights issue. Both are correct on their own basis. On the rebased 18p against the 387.73p theoretical ex-rights price, the implied yield is about 4.6%, with growth from that level intended to track CPIH.

The Openbook read

Momentum is the clearest casualty and the score goes sharply negative. A move to multi-year lows on a dilutive raise and a dividend cut is not a technical wobble, and there is no near-term catalyst to arrest it before the half-year numbers. The mechanics of the raise compound it: nil-paid trading and the rump placing process add supply into a falling market.

Growth genuinely improves, and this is the part the headline obscures. RCV growth of more than 40% across AMP8, up from 34%, is a step change in the asset base on which Pennon earns its allowed return, and £3.6bn of capital investment is the mechanism. Revenue is already moving: FY2025/26 group revenue rose 23% to £1.29bn, with South West Water at £937.8m against £737.7m. Guidance for FY2026/27 is for water revenue up £50m to £70m and underlying EBITDA growth of 5% to 10%. The caveat is that about £170m of the increment depends on cost change processes in 2027 and 2028 that have not yet been approved, so a slice of the growth is regulatory rather than contracted.

Profitability is recovering from a genuinely poor base and the direction is right. Underlying EBITDA rose 55% to £519.2m in FY2025/26 and statutory pre-tax profit swung to £114.4m from a £72.7m loss. The half-year pattern was the same: underlying EBITDA of £254.4m in the six months to 30 September 2025, up 55%, with pre-tax profit of £65.9m against a £38.8m loss. But a 55% EBITDA increase off a loss-making year is a recovery score rather than a quality score, and rising net interest costs on a growing debt book sit between EBITDA and the bottom line.

Solvency is where this story actually lives, and it is the factor the raise is designed to address. Net debt stood at £4,508.9m at 31 March 2026, up from £4,078.2m, with water group gearing of 61.8% of RCV — inside the 55% to 65% policy range, but with the top of that range in sight and a £3.6bn capital programme still to fund. Group gearing was 63.2% at the September 2025 half-year against South West Water's standalone 60.1%. The £550m equity injection and the explicit commitment to stay below 65% of RCV throughout AMP8 improve the score meaningfully on a pro-forma basis. The honest qualification is that the same commitment was made in 2025 and did not hold, so the score should carry a discount for the possibility of a third call if the programme grows again.

Reward/Risk is the factor doing the most work. The reward case is mechanical and real: a larger regulated asset base, a dividend reset to a level the company says can grow with CPIH rather than one it was straining to cover, gearing headroom restored, and a share price at levels last seen 15 years ago. The risk case is that the deep discount is not a bargain but a measure of how much persuasion the underwriters judged necessary, and that Haslett's turnaround is a multi-year execution task whose benefits are promised rather than delivered. Reward/Risk improves from where it stood a week ago, because the balance sheet question has been answered in cash rather than deferred. It does not become comfortable, because what has to go right now is operational — and operational delivery is precisely what two equity raises in 20 months suggest has been the weak point.

The read-across

Pennon is not an isolated case, and the comparison with United Utilities is instructive because it is the same problem solved differently. United Utilities has lifted its AMP8 capital guidance from about £9bn to about £11.5bn and is funding the equity share of that roughly £2.5bn increase with an £800m placing, structured to keep gearing inside the same 55% to 65% range. Its RCV gearing was 60% at FY26, it reported a regulatory return of 13.0% ahead of guidance, and it targets asset base growth of around 10% compound to 2030. Approximately £1.4bn of its increment has been submitted to Ofwat, the remainder expected through future re-openers. Morgan Stanley described that raise as a positive, on the grounds that funding questions were answered immediately.

The structural read is that AMP8 is costing materially more than the Final Determinations assumed, across the sector, and that equity is being called to bridge the gap. The difference between the two names is not the diagnosis but the starting point: United Utilities raised a smaller proportion of its market value through a placing, kept its dividend, and had already fully funded its base programme. Pennon needed a rights issue at a 35.5% discount to TERP and had to cut the dividend to do it. Investors screening UK water on the Openbook screener should treat above-determination capex as the sector's defining feature of the next three years, then separate the names funding it from strength from those funding it from necessity. Severn Trent is the obvious third data point, and whether it follows decides whether this is a Pennon problem or a sector one.

What to watch next

The immediate sequence is the rights issue timetable itself: nil-paid dealings, the acceptance deadline and the rump placing. The 2025 issue saw underwriters place about 7.4% of the new shares as rump; the equivalent figure this time is a clean read on how much appetite the register actually has.

The first substantive checkpoint is the half-year results for 2026/27, scheduled for 1 December 2026 on Pennon's confirmed financial calendar. Three things matter there. First, whether the FY2026/27 guidance of £50m to £70m of additional water revenue and 5% to 10% underlying EBITDA growth is intact. Second, pro-forma gearing after the raise, and whether it leaves visible headroom below 65% of RCV rather than hugging it. Third, the first evidence on the operational pillars — leakage, pollution and asset reliability metrics are where a turnaround either shows up or does not.

Beyond that, the 2027 and 2028 Ofwat cost change processes are the gating item for about £170m of the programme, and the proposed Pennon Power disposal is a discrete event with about £25m attached. The dividend is now explicitly a CPIH-linked series from a rebased base, so the FY2026/27 declaration is where the market finds out whether roughly £125m is a floor the company intends to defend or a staging post.